Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection

PURPOSE: The aim of this study was to identify and validate novel predictive and/or prognostic serum proteomic biomarkers in patients with epithelial ovarian cancer (EOC) treated as part of the phase III international ICON7 clinical trial. EXPERIMENTAL DESIGN: ICON7 was a phase III international tri...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Collinson, Fiona, Hutchinson, Michelle, Craven, Rachel A., Cairns, David A., Zougman, Alexandre, Wind, Tobias C., Gahir, Narinder, Messenger, Michael P., Jackson, Sharon, Thompson, Douglas, Adusei, Cybil, Ledermann, Jonathan, Hall, Geoffrey, Jayson, Gordon C., Selby, Peter J., Banks, Rosamonde E.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3780518/
https://ncbi.nlm.nih.gov/pubmed/23935036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-0489
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki